Low bone mineral density in a case of mosaicism Klinefelter syndrome: Rapid response to testosterone therapy

被引:2
作者
Yamauchi, M [1 ]
Tadano, M [1 ]
Fukunaga, Y [1 ]
Inoue, D [1 ]
Minamikawa, V [1 ]
Koshiyama, H [1 ]
机构
[1] Hyogo Prefectural Amagasaki Hosp, Dept Internal Med, Div Endocrinol & Metab, Amagasaki, Hyogo 6600828, Japan
关键词
Klinefelter syndrome; osteoporosis; mosaicism; testosterone treatment; diabetes mellitus;
D O I
10.1507/endocrj.45.601
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Male hypogonadism has been recognized as one of the major causes of secondary osteoporosis, but most cases seem to be left undiagnosed. We report a 54-year-old case of mosaicism Klinefelter syndrome lacking typical clinical features such as tall stature or low intelligence, who was found to have marked decrease in lumbar bone mineral density (BMD: 0.686 g/cm(2)) during treatment of diabetes mellitus. In investigation for etiologies of secondary osteoporosis, he was diagnosed as having mosaicism Klinefelter syndrome (XXY/XY/XX). Although he was infertile, he lacked typical clinical features of Klinefelter syndrome. Testosterone replacement was started, which resulted in an increase in BMD up to 0.712 g/cm(2) two months after the initiation of therapy. The fact that BMD increased shortly after the initiation of testosterone replacement therapy in the present case supported a beneficial effect of testosterone on BMD, as recently suggested in idiopathic hypogonadotropic hypogonadism. Although the present case was diagnosed as having mosaicism Klinefelter syndrome by investigating etiologies for osteoporosis, it may be stressed that male hypogonadism, in general, should be adequately suspected in the presence of infertility and from the findings of physical examination.
引用
收藏
页码:601 / 604
页数:4
相关论文
共 18 条
[1]  
BEHER HM, 1997, J CLIN ENDOCR METAB, V82, P2386
[2]   Emerging issues in androgen replacement therapy [J].
Bhasin, S ;
Bremner, WJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :3-8
[3]   Testosterone replacement increases fat-free mass and muscle size in hypogonadal men [J].
Bhasin, S ;
Storer, TW ;
Berman, N ;
Yarasheski, KE ;
Clevenger, B ;
Phillips, J ;
Lee, WP ;
Bunnell, TJ ;
Casaburi, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :407-413
[4]   Effect of testosterone and estradiol in a man with aromatase deficiency [J].
Carani, C ;
Qin, K ;
Simoni, M ;
FaustiniFustini, M ;
Serpente, S ;
Boyd, J ;
Korach, KS ;
Simpson, ER .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) :91-95
[5]   IDENTIFICATION OF ANDROGEN RECEPTORS IN NORMAL HUMAN OSTEOBLAST-LIKE CELLS [J].
COLVARD, DS ;
ERIKSEN, EF ;
KEETING, PE ;
WILSON, EM ;
LUBAHN, DB ;
FRENCH, FS ;
RIGGS, BL ;
SPELSBERG, TC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (03) :854-857
[6]   OSTEOPOROSIS IN MEN WITH IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM [J].
FINKELSTEIN, JS ;
KLIBANSKI, A ;
NEER, RM ;
GREENSPAN, SL ;
ROSENTHAL, DI ;
CROWLEY, WF .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (03) :354-361
[7]   INCREASES IN BONE-DENSITY DURING TREATMENT OF MEN WITH IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM [J].
FINKELSTEIN, JS ;
KLIBANSKI, A ;
NEER, RM ;
DOPPELT, SH ;
ROSENTHAL, DI ;
SEGRE, GV ;
CROWLEY, WF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (04) :776-783
[8]   DIRECT MODULATION BY ANDROGENS OF THE RESPONSE OF HUMAN-BONE CELLS (SAOS-2) TO HUMAN PARATHYROID-HORMONE (PTH) AND PTH-RELATED PROTEIN [J].
FUKAYAMA, S ;
TASHJIAN, AH .
ENDOCRINOLOGY, 1989, 125 (04) :1789-1794
[9]  
Fukunaga Y, 1997, ARCH INTERN MED, V157, P2668
[10]   Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover [J].
Guo, CY ;
Jones, TH ;
Eastell, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :658-665